Launch of Tom Biosciences' PGI Technology for Gene Therapies

This chapter discusses the launch of Tom Biosciences, a company aiming to develop curative gene therapies using their improved version of paste technology called PGI. It explores the capabilities of PGI, the involvement of co-founders, licensing requirements, and the company's plans for developing therapies for liver and autoimmune diseases.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app